Sajad Khiali

487 total citations
23 papers, 325 citations indexed

About

Sajad Khiali is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Sajad Khiali has authored 23 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Sajad Khiali's work include COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Long-Term Effects of COVID-19 (4 papers). Sajad Khiali is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Long-Term Effects of COVID-19 (4 papers). Sajad Khiali collaborates with scholars based in Iran. Sajad Khiali's co-authors include Taher Entezari‐Maleki, Parvin Sarbakhsh, Afshin Gharekhani, Hossein Bannazadeh Baghi, Mohammadreza Taban Sadeghi, Naser Safaie, Haleh Rezaee, Naser Aslanabadi, Parham Maroufi and Hadi Hamishehkar and has published in prestigious journals such as European Journal of Pharmacology, Archives of Virology and European Journal of Clinical Pharmacology.

In The Last Decade

Sajad Khiali

21 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sajad Khiali Iran 9 177 107 62 32 23 23 325
Mohammad Qaddoumi Kuwait 5 125 0.7× 39 0.4× 97 1.6× 58 1.8× 3 0.1× 9 271
Atish Gheware India 9 67 0.4× 35 0.3× 113 1.8× 43 1.3× 5 0.2× 16 340
Amir Yarahmadi Iran 8 69 0.4× 46 0.4× 67 1.1× 11 0.3× 5 0.2× 19 291
Giuseppe Magro Italy 5 188 1.1× 100 0.9× 64 1.0× 18 0.6× 3 0.1× 20 303
Evmorfia Aivalioti Greece 7 116 0.7× 50 0.5× 73 1.2× 73 2.3× 2 0.1× 20 350
Bahman Amani Iran 10 296 1.7× 120 1.1× 65 1.0× 37 1.2× 1 0.0× 27 462
Lihan Shen China 9 169 1.0× 97 0.9× 79 1.3× 65 2.0× 1 0.0× 19 358
Gabriel Pasquarelli-do-Nascimento Brazil 8 86 0.5× 43 0.4× 71 1.1× 85 2.7× 2 0.1× 11 346
Manuel Alejandro Vargas-Vargas Mexico 5 112 0.6× 45 0.4× 57 0.9× 65 2.0× 2 0.1× 13 284

Countries citing papers authored by Sajad Khiali

Since Specialization
Citations

This map shows the geographic impact of Sajad Khiali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajad Khiali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajad Khiali more than expected).

Fields of papers citing papers by Sajad Khiali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sajad Khiali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajad Khiali. The network helps show where Sajad Khiali may publish in the future.

Co-authorship network of co-authors of Sajad Khiali

This figure shows the co-authorship network connecting the top 25 collaborators of Sajad Khiali. A scholar is included among the top collaborators of Sajad Khiali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajad Khiali. Sajad Khiali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khiali, Sajad, et al.. (2024). Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial. Journal of Cardiovascular and Thoracic Research. 16(1). 49–54.
2.
3.
4.
Khiali, Sajad, et al.. (2023). Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review. Pharmaceutical Medicine. 37(2). 139–151. 7 indexed citations
5.
Khiali, Sajad, et al.. (2023). SGLT2 Inhibitors’ Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review. The Journal of Clinical Pharmacology. 63(12). 1307–1323. 8 indexed citations
6.
Khiali, Sajad, et al.. (2022). Investigational antiviral drugs for the treatment of COVID-19 patients. Archives of Virology. 167(3). 751–805. 8 indexed citations
7.
Khiali, Sajad, et al.. (2022). SARS-CoV-2 and probable lung cancer risk. Bioimpacts. 12(3). 291–292. 7 indexed citations
8.
Khiali, Sajad, et al.. (2022). Comprehensive Review on Molnupiravir in COVID-19: A Novel Promising Antiviral to Combat the Pandemic. Future Microbiology. 17(5). 377–391. 14 indexed citations
9.
Khiali, Sajad, et al.. (2021). Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. European Journal of Pharmacology. 897. 173926–173926. 82 indexed citations
10.
Khiali, Sajad, et al.. (2021). Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review. The Journal of Clinical Pharmacology. 61(4). 429–460. 18 indexed citations
11.
12.
Khiali, Sajad, et al.. (2021). Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review. European Journal of Pharmacology. 912. 174582–174582. 35 indexed citations
13.
Khiali, Sajad, et al.. (2021). Pharmacist-Directed Self-Management of Blood Pressure Versus Conventional Management in Patients with Hypertension: A Randomized Control Trial. High Blood Pressure & Cardiovascular Prevention. 28(3). 283–290. 4 indexed citations
14.
Khiali, Sajad, et al.. (2021). Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review. Pharmaceutical Sciences. 1 indexed citations
15.
Aslanabadi, Naser, et al.. (2021). Colchicine for the Prevention of Myocardial Injury Following Elective PCI: A Randomized Clinical Trial. Pharmaceutical Sciences. 2 indexed citations
16.
Safaie, Naser, et al.. (2020). The Impact of Clinical Pharmacist Interventions on Medication Errors Management in the Postoperative Cardiac Intensive Care Unit. Pharmaceutical Sciences. 27(3). 433–438. 2 indexed citations
17.
Khiali, Sajad, et al.. (2020). A comprehensive review on sarilumab in COVID-19. Expert Opinion on Biological Therapy. 21(5). 615–626. 33 indexed citations
18.
Khiali, Sajad, et al.. (2020). Vancomycin Utilization Evaluation in a Major Teaching Hospital in West of Iran. 1 indexed citations
19.
Khiali, Sajad & Taher Entezari‐Maleki. (2020). Anticoagulation in COVID-19: DDI Perspective. Clinical and Applied Thrombosis/Hemostasis. 26. 2874357985–2874357985. 8 indexed citations
20.
Khiali, Sajad, Afshin Gharekhani, & Taher Entezari‐Maleki. (2018). Isotretinoin; A review on the Utilization Pattern in Pregnancy. Advanced Pharmaceutical Bulletin. 8(3). 377–382. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Qaddoumi Breakdown of academic impact, for papers by Atish Gheware Breakdown of academic impact, for papers by Amir Yarahmadi Breakdown of academic impact, for papers by Giuseppe Magro Breakdown of academic impact, for papers by Evmorfia Aivalioti Breakdown of academic impact, for papers by Bahman Amani Breakdown of academic impact, for papers by Lihan Shen Breakdown of academic impact, for papers by Gabriel Pasquarelli-do-Nascimento Breakdown of academic impact, for papers by Manuel Alejandro Vargas-Vargas
Rankless by CCL
2026